Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	28.53	31.92	24.28	10.95	6.99
Research & Development	71.29	87.82	69.04	32.6	25.11
Operating Expenses	99.82	119.73	93.32	43.55	32.1
Operating Income	-99.82	-119.73	-93.32	-43.55	-32.1
Interest Expense / Income	0	0	0	0	2.66
Other Expense / Income	-24.02	-15.54	-6.47	-1.89	-1.21
Pretax Income	-75.8	-104.2	-86.85	-41.66	-33.55
Net Income	-75.8	-104.2	-86.85	-41.66	-33.55
Shares Outstanding (Basic)	219	217	198	98	207
Shares Outstanding (Diluted)	219	217	198	98	207
Shares Change	1.00%	9.52%	102.90%	-52.81%	-
EPS (Basic)	-0.35	-0.48	-0.44	-0.43	-0.16
EPS (Diluted)	-0.35	-0.48	-0.44	-0.43	-0.16
Free Cash Flow	-68.05	-96.47	-68.47	-36.67	-25.09
Free Cash Flow Per Share	-0.31	-0.45	-0.35	-0.38	-0.12
EBITDA	-75.65	-103.72	-86.48	-41.56	-30.88
Depreciation & Amortization	0.16	0.48	0.37	0.1	0.01
EBIT	-75.8	-104.2	-86.85	-41.66	-30.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).